The ability of the vaccines today to generate a long-lasting protection against infections varies greatly from one vaccine to another. The yellow fever vaccine…

Vaccine Response

~Estimated

~$10 – $6,250

Emory UniversityNCT05801978

Phase 1

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

The goal of this research is to learn more about ZADAXIN® (trade name; thymalfasin generic; Ta1 for short) and determine if Ta1 has any benefit in increasing t…

Vaccine ResponseCOVID-19 VaccineImmune Response to Covid 19 Vaccination

~Estimated

~$10 – $6,250

The Methodist Hospital Research InstituteNCT06821100

Phase 4

EVax-3: Human Upper and Lower Airway Mucosal Immune Response to FluMist Vaccination

The goal of this clinical trial is to measure the immune response in the blood, nose, and lungs after participants receive either the FDA-approved inactivated …

Healthy Young AdultsInfluenza VaccinesInfluenza Vaccine Response

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT07177417